PET technology for drug development in psychiatry

Positron emission tomography (PET) is a non‐invasive imaging method to measure the molecule in vivo. PET imaging can evaluate the central nervous system drugs as target engagement in the human brain. For antipsychotic drugs, adequate dopamine D2 receptor occupancy (“therapeutic window”) is reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Arakawa, Ryosuke, Takano, Akihiro, Halldin, Christer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722687/
https://www.ncbi.nlm.nih.gov/pubmed/32463584
http://dx.doi.org/10.1002/npr2.12084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722687/
https://www.ncbi.nlm.nih.gov/pubmed/32463584
http://dx.doi.org/10.1002/npr2.12084

Ejemplares similares